| 臺大學術典藏 |
2022-04-14T23:27:22Z |
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
|
WANG-HUEI SHENG; SUI-YUAN CHANG; Lin, Pin Hung; MING-JU HSIEH; Chang, Hao Hsiang; Cheng, Chien Yu; HUNG-CHIH YANG; Pan, Ching Fu; Ieong, Si Man; Chao, Tai Ling; Chen, Jang Pin; Cheng, Shu Hsing; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-03-14T23:44:58Z |
Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae
|
Wang, Yu Ping; Chen, Yen Hao; Hung, I. Cheng; Chu, Po Hsun; Chang, Yu Han; Lin, Yi Tsung; HUNG-CHIH YANG; JIN-TOWN WANG |
| 臺大學術典藏 |
2022-02-14T23:55:08Z |
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma
|
Wang, Sung Yin; TUNG-HUNG SU; BANG-BIN CHEN; CHUN-JEN LIU; CHEN-HUA LIU; HUNG-CHIH YANG; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-15T00:07:35Z |
Recent progress and future prospective in HBV cure by CRISPR/cas
|
Yang, Yu Chan; HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Isolation or De-isolation? Measuring the Infectivity of Severe Acute Respiratory Syndrome Coronavirus 2
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, Shang Chin; Cheng, Pin Nan; CHEN-HUA LIU; HUNG-CHIH YANG; TUNG-HUNG SU; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
TUNG-HUNG SU; Peng, Cheng Yuan; Chang, Shan Han; Tseng, Tai Chung; CHUN-JEN LIU; CHI-LING CHEN; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-08-15T00:07:45Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-08-15T00:07:45Z |
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen
|
YA-WEN YANG; CHIEN-CHIA CHEN; Yang, Ching Yao; Lee, Chih Yuan; HUNG-CHIH YANG; BOR-LUEN CHIANG; YA-HUI CHUANG; Wu, Tiffany E.; HONG-SHIEE LAI; MENG-KUN TSAI |
| 臺大學術典藏 |
2021-07-12T03:12:56Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru; HUNG-CHIH YANG; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-07-12T02:50:43Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru; HUNG-CHIH YANG; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-07-12T02:44:52Z |
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
|
HUNG-CHIH YANG; | Shen L; | Siliciano R.F; | Pomerantz J.L. |
| 臺大學術典藏 |
2021-07-12T02:44:52Z |
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
|
HUNG-CHIH YANG; | Xing S; | Shan L; | O'Connell K; | Dinoso J; | Shen A; | Zhou Y; | Shrum C.K; | Han Y; | Liu J.O; | Zhang H; | Margolick J.B; | Siliciano R.F. |
| 臺大學術典藏 |
2021-07-12T02:44:51Z |
Primary cell models of HIV latency
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:49Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
HUNG-CHIH YANG; | Chen C.-L; | Shen Y.-C; | Peng C.-Y; | Liu C.-J; | Tseng T.-C; | Su T.-H; | Chuang W.-L; | Yu M.-L; | Dai C.-Y; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:45Z |
Hepatitis B virus: Pathogenesis and host immune response
|
HUNG-CHIH YANG; | Yeh S.-H; | Chen P.-J; | Chen D.-S. |
| 臺大學術典藏 |
2021-07-12T02:44:44Z |
Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:44Z |
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:39Z |
Looking into the crystal ball: biomarkers for outcomes of HBV infection
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:37Z |
Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B
|
HUNG-CHIH YANG; | Shih Y.-F; | Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
|
HUNG-CHIH YANG; | Chen P.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
Viral factors affecting disease progression
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:31Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
HUNG-CHIH YANG; | Tsou H.-H; | Pei S.-N; | Chang C.-S; | Chen J.-H; | Yao M; | Lin S.-J; | Lin J; | Yuan Q; | Xia N; | Liu T.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:24Z |
Epidemiology and management of HCV Infection
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943�V2020)
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T02:10:37Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG; TUNG-HUNG SU; Tseng, Tai Chung; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU; DING-SHINN CHEN; Chen, Pei-Jer; HUNG-CHIH YANG; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-05-21T11:40:23Z |
Direct comparison of biopsy techniques for hepatic malignancies
|
Huang, Shang Chin; JA-DER LIANG; Hsu, Shih Jer; Hong, Tzu Chan; HUNG-CHIH YANG; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-04-21T23:30:27Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG; TUNG-HUNG SU; Tseng, Tai Chung; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU; DING-SHINN CHEN; Chen, Pei-Jer; HUNG-CHIH YANG; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng, Tai Chung; CHUN-JEN LIU; Yang, Wan Ting; Hsu, Chen Yang; CHUN-MING HONG; SU, TUNG-HUNG; Tsai, Cheng Hsueh; CHI-LING CHEN; HUNG-CHIH YANG; CHEN-HUA LIU; HSIU-HSI CHEN; Chen, Pei-Jer; Kao, Jia-Horng |
| 臺大學術典藏 |
2019-08-29T07:40:12Z |
Viral factors affecting disease progression
|
Hung-Chih Yang; HUNG-CHIH YANG |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-07-18T03:51:40Z |
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection
|
Lee, Yu-Hsiang;Huang, Juin-Hua;Chang, Tzu-Hsuan;Hung-Chih Yang;Betty An-Ye Wu-Hsieh; Lee, Yu-Hsiang; Huang, Juin-Hua; Chang, Tzu-Hsuan; HUNG-CHIH YANG; BETTY AN-YE WU-HSIEH |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
Su, T.-H.;Yang, H.-C.;Tseng, T.-C.;Liou, J.-M.;Liu, C.-H.;Chen, C.-L.;Chen, P.-J.;Chen, D.-S.;Liu, C.-J.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu, C.-H.;Sun, H.-Y.;Liu, C.-J.;Sheng, W.-H.;Hsieh, S.-M.;Lo, Y.-C.;Liu, W.-C.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Tseng, T.-C.;Chen, P.-J.;Chen, D.-S.;Hung, C.-C.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
|
Papatheodoridis, G.V.;Manolakopoulos, S.;Su, T.-H.;Siakavellas, S.;Liu, C.-J.;Kourikou, A.;Yang, H.-C.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
Tung-Hung Su;Chun-Hsun Liao;Chen-Hua Liu;Kai-Wen Huang;Tai-Chung Tseng;Hung-Chih Yang;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:05:07Z |
A noninvasive diagnosis of hepatic fibrosis by BioFibroScoreR in chronic hepatitis C patients
|
HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; CHUN-MING HONG; DING-SHINN CHEN; JIA-HORNG KAO; Liu, C.-H.;Liu, C.-J.;Hong, C.-M.;Su, T.-H.;Yang, H.-C.;Chen, K.-M.;Huang, Y.-P.;Yeh, Y.-M.;Tien, H.-L.;Liu, Y.-C.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J. |
| 臺大學術典藏 |
2018-09-10T18:04:53Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
JIA-HORNG KAO; KAI-WEN HUANG; TUNG-HUNG SU; DING-SHINN CHEN; CHEN-HUA LIU; CHUN-JEN LIU; HUNG-CHIH YANG; Su, T.-H. and Shiau, C.-W. and Jao, P. and Yang, N.-J. and Tai, W.-T. and Liu, C.-J. and Tseng, T.-C. and Yang, H.-C. and Liu, C.-H. and Huang, K.-W. and Hu, T.-C. and Huang, Y.-J. and Wu, Y.-M. and Chen, L.-J. and Chen, P.-J. and Chen, D.-S. and Chen, K.-F. and Kao, J.-H. |
